share_log

EFFECT: Others

EFFECT: Others

EFFECT:其他
美股SEC公告 ·  08/28 06:09
Moomoo AI 已提取核心信息
SeaStar Medical Holding Corp has announced the effectiveness of a Form S-3 filing with the United States Securities and Exchange Commission (SEC) as of August 27, 2024, at 4:30 P.M. The filing, under the file number 333-280683, is a significant step for the company, indicating that it has met the necessary SEC requirements to issue securities under the Securities Act. This development could potentially pave the way for SeaStar Medical to raise capital through the sale of securities.
SeaStar Medical Holding Corp has announced the effectiveness of a Form S-3 filing with the United States Securities and Exchange Commission (SEC) as of August 27, 2024, at 4:30 P.M. The filing, under the file number 333-280683, is a significant step for the company, indicating that it has met the necessary SEC requirements to issue securities under the Securities Act. This development could potentially pave the way for SeaStar Medical to raise capital through the sale of securities.
SeaStar医疗控股公司已宣布在2024年8月27日下午4:30时与美国证券交易委员会(SEC)提交的S-3表格生效。根据文件号333-280683,该申请对公司来说是一个重要的步骤,表明其已满足发行证券的《证券法》的必要SEC要求。这一进展有潜力为SeaStar医疗通过发行证券筹集资本。
SeaStar医疗控股公司已宣布在2024年8月27日下午4:30时与美国证券交易委员会(SEC)提交的S-3表格生效。根据文件号333-280683,该申请对公司来说是一个重要的步骤,表明其已满足发行证券的《证券法》的必要SEC要求。这一进展有潜力为SeaStar医疗通过发行证券筹集资本。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息